FATE THERAPEUTICS INC
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: 858.875.1803
EIN: 651311552
State Location: CA
- Nasdaq:FATE
Form: 8-K/A
Filing Date: 17 Jun 2025Report Date: 29 May 2025
Accepted: 17 Jun 2025 06:01 p.m.
Accession Number: 0001193125-25-142037
File Number: 001-36076
Film Number: 251053237
Items: 5.07
Documents
Primary Document: 8-K/A
Accepted: 17 Jun 2025 06:01 p.m.
0001193125-25-142037-index-headers.html
Last Modified: 17 Jun 2025 02:01 p.m.
0001193125-25-142037-index.html
Last Modified: 17 Jun 2025 02:01 p.m.
0001193125-25-142037-xbrl.zip
Last Modified: 17 Jun 2025 02:01 p.m.
0001193125-25-142037.txt
Last Modified: 17 Jun 2025 02:01 p.m.
FilingSummary.xml
Last Modified: 17 Jun 2025 02:01 p.m.
MetaLinks.json
Last Modified: 17 Jun 2025 02:01 p.m.
R1.htm
Last Modified: 17 Jun 2025 02:01 p.m.
Show.js
Last Modified: 17 Jun 2025 02:01 p.m.
d35713d8ka_htm.xml
Last Modified: 17 Jun 2025 02:01 p.m.
fate-20250529.xsd
Last Modified: 17 Jun 2025 02:01 p.m.
fate-20250529_lab.xml
Last Modified: 17 Jun 2025 02:01 p.m.
fate-20250529_pre.xml
Last Modified: 17 Jun 2025 02:01 p.m.
report.css
Last Modified: 17 Jun 2025 02:01 p.m.